COMPANY INTELLIGENCEWhat the linked records show
MedtechLedger currently links 5 FDA records to the applicant name Channel Medsystems, Inc.. It includes 1 original PMA approval. 3 entries are PMA supplements. 1 entry is a 30-day notice. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Mar 28, 2019 to Nov 3, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code MNB appears in 5 of the 5 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
The largest PMA family in this collection is P180032, with 5 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes. 2 linked filings have a current plain-language explanation checked against the recorded FDA decision.
Applicant mailing address recorded by FDA: 5858 Horton St., Suite 200, Emeryville, CA, 94608. Recorded on P180032/S025, decision dated Nov 3, 2026.
Device categories in this collection
Device, Thermal Ablation, Endometrial.
Changes described in PMA records
The FDA recorded an approval decision dated 2026-11-03 for PMA supplement P180032/S025, submitted by Channel Medsystems, Inc. The supplement is classified as a Real-Time Process review with a stated reason of Change Design/Components/Specifications/Material. The listed title covers the Cerene Cryotherapy Device (model FGS-7000) together with Exhaust Collection Bag components (model FGS-8000 and a further truncated entry).
The recorded statement limits the action to approval of minor design changes to the Exhaust Collection Bag. This is a supplement-level decision, not a new approval of the Cerene Cryotherapy Device as a whole. The source does not describe the specific design changes, their technical rationale, or any supporting data, and it does not state clinical implications; those details would reside in the supplement review documents, which were not provided.
The device category is thermal ablation, endometrial, with product code MNB and specialty Obstetrics/Gynecology. The source gives no information on labeling changes, postmarket requirements, or effective date beyond the recorded decision date.
FDA approval-order wording
Approval for minor design changes to the Exhaust Collection Bag.
Nov 3, 2026 · Real-Time ProcessThe FDA record for P180032/S024 lists the Cerene cryotherapy device, a thermal endometrial ablation device under product code MNB, with a decision of OK30 dated 2026-09-15. The supplement is a 30-Day Notice filed by Channel Medsystems, Inc. under the reason Process Change - Manufacturer/Sterilizer/Packager/Supplier. The stated change is a change in supplier of the uterine liner material. The record does not identify the prior or new supplier, the liner's material or function, or what testing supported the notice.
The S024 number ties this filing to the original PMA P180032 as a supplement, not as a new approval of the whole system. A supplier change notice is a manufacturing notification, and its reported purpose is distinct from independent proof of safety or clinical effectiveness. The record gives no clinical data, performance results, indications, or review conclusions beyond the OK30 decision code and date.
FDA approval-order wording
a change in supplier of the uterine liner material
Sep 15, 2026 · 30-Day NoticeFDA’s recorded scope: The recommended decision for this file is Approve PMA GMP without inspection. This recommendation is based on transferring a low-risk labeling activity to a manufacturing site (and sponsor) previously approved under the PMA.
Jul 8, 2026 · Normal 180 Day TrackFDA’s recorded scope: Approval for introducing a coating to the controller printed circuit board.
Dec 18, 2025 · Special (Immediate Track)FDA’s recorded scope: Approval for the Cerene Cryotherapy Device. This device is indicated for endometrial cryoablation in premenopausal women with heavy menstrual bleeding due to benign causes for whom child bearing is complete.
Mar 28, 2019Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.